Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

And do not stop taking Aricept unless your doctor recommends it. Aricept may cause mild side effects other than those listed above. See the drug’s prescribing information for details.

In patients with moderate including moderately-severe AD (20 > MMSE ≥ 10), donepezil also dominates memantine, although savings are smaller, averaging €1,960 per patient (€2,097 undiscounted ...

Donepezil (Aricept) was approved in 1996, Rivastigmine (Exelon) was approved in 2000, and galantamine (Reminyl) was approved in 2001. In October, 2003, the FDA approved Memantine (Namenda) for the ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Namzaric is a medication that combines donepezil and memantine. As Alzheimer’s disease progresses, it can cause several behavioral and mood symptoms, such as wandering, restlessness ...

The new study was conducted to explore whether combining two existing drugs, Donepezil and Memantine, could offer a more effective treatment approach. Previous research had suggested that these ...

Aricept (donepezil) is a brand-name drug prescribed for dementia related to Alzheimer’s disease. Aricept has interactions with other drugs and certain supplements. Examples include ...

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer’s Disease on Donepezil (CONCERT ... vision and cognition. Memantine for the Frontal and Temporal Subtypes of ...